Monoclonal antibodies against the connexin43-interacting protein CIP85

Kimberly Cochrane1, John M Berestecky, Carolynn Kitamura

  • 1Natural Products and Cancer Biology Program, Cancer Research Center of Hawaii, Honolulu, Hawaii, USA.

Hybridoma (2005)
|October 28, 2009
PubMed

Insights

Researchers developed new monoclonal antibodies against CIP85, a protein interacting with connexin43 (Cx43). These tools will help understand CIP85

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Connexin43 (Cx43) is a key protein in gap junctions, facilitating intercellular communication.
  • CIP85 (connexin43-interacting protein of 85 kDa) interacts with the carboxyl-terminal tail of Cx43.
  • This interaction is linked to increased Cx43 turnover, potentially via lysosomal pathways.

Purpose of the Study:

  • To report the successful production of monoclonal antibodies (MAbs) against CIP85.
  • To establish tools for detecting CIP85 expression across various species.
  • To facilitate research into CIP85's functional roles, particularly its influence on Cx43 trafficking and gap junction function.

Main Methods:

  • Production of monoclonal antibodies (MAbs) against CIP85.
  • Validation of MAbs using immunoblotting, immunoprecipitation, and immunofluorescence microscopy.
  • Detection of CIP85 expression in multiple species.

Main Results:

  • The study successfully generated MAbs specific to CIP85.
  • These MAbs demonstrated efficacy in detecting CIP85 in various experimental assays.
  • CIP85 was detected in multiple species, indicating conserved expression.

Conclusions:

  • The developed MAbs are valuable reagents for studying CIP85.
  • These antibodies will aid in elucidating CIP85's role in Cx43 trafficking and degradation.
  • Understanding CIP85's function is crucial for comprehending gap junction regulation and intercellular communication.